New ECG gadget put to the test for spotting irregular heartbeats
NCT ID NCT06071754
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new device called Masimo INVSENSOR00057 that records a single-lead ECG, similar to a standard lead I. Researchers compared its heart rate and atrial fibrillation detection against standard measurements in 365 adults, including healthy people and those with AFib. The goal was to see if the device works accurately enough for everyday use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Masimo INVSENSOR00057 (ECG monitoring device)
What this could lead to
If successful, this device could provide a reliable way to detect atrial fibrillation and measure heart rate, potentially improving early diagnosis.
What could go wrong
This is a completed validation study, not a treatment trial. The device may not outperform existing ECG methods, and results may not apply to all populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cone Health
Greensboro, North Carolina, 27401, United States
-
Masimo Clinical Lab
Irvine, California, 92618, United States
-
Medication Management
Greensboro, North Carolina, 27405, United States
-
PCA Cardiology
Laguna Hills, California, 92653, United States